Avanafil for the Treatment of Erectile Dysfunction: A Multicenter, Randomized, Double-Blind Study in Men With Diabetes Mellitus

Abstract Objective To prospectively assess the safety and effectiveness of the investigational phosphodiesterase 5 inhibitor avanafil to treat erectile dysfunction in men with diabetes mellitus. Patients and Methods This 12-week, multicenter, double-blind, placebo-controlled study conducted between...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Mayo Clinic proceedings 2012-09, Vol.87 (9), p.843-852
Hauptverfasser:	Goldstein, Irwin, MD, Jones, LeRoy A., MD, Belkoff, Laurence H., DO, Karlin, Gary S., MD, Bowden, Charles H., MD, Peterson, Craig A., MS, Trask, Brenda A., BS, Day, Wesley W., PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	Avanafil Biological and medical sciences Complications and side effects Diabetes Diabetes Mellitus Diabetes. Impaired glucose tolerance Dosage and administration Double-Blind Method Drug therapy Endocrine pancreas. Apud cells (diseases) Endocrinopathies Erectile Dysfunction - drug therapy Etiopathogenesis. Screening. Investigations. Target tissue resistance General aspects Humans Impotence Internal Medicine Least-Squares Analysis Male Medical sciences Middle Aged Original Penile Erection - drug effects Placebos Prospective Studies Pyrimidines - therapeutic use Risk factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!